Skip to main content

Table 1 Characteristics of the study population: non-sudden cancer deaths ( N= 2037)

From: Care provided and care setting transitions in the last three months of life of cancer patients: a nationwide monitoring study in four European countries

Characteristics

Belgium (N = 595)

The Netherlands (N = 335)

Italy (N = 830)

Spain (N = 277)

p-valueb

 

N(%)

N(%)

N(%)

N(%)

 

Age group

    

.156

18-64

160(27.1)

90(26.9)

195(23.5)

59(21.3)

 

65-74

131(22.2)

94(28.1)

210(25.3)

65(23.5)

 

75-84

184(31.2)

103(30.7)

257(31.0)

97(35.0)

 

85 or above

115(19.5)

48(14.3)

168(20.2)

56(20.2)

 

Mean

72.5

71.9

73.6

74.2

 

Gender

    

<.001

M

328(55.1)

177(53.2)

448(54.0)

186(67.6)

 

F

267(44.9)

156(46.8)

382(46.0)

89(32.4)

 

Types of malignancy

    

<.001

Lung

148(24.9)

80(25.0)

182(26.5)

53(19.8)

 

Breast

51(8.6)

33(10.3)

57(8.3)

11(4.1)

 

Colorectal

69(11.6)

38(11.9)

102(14.8)

49(18.3)

 

Prostate

25(4.2)

23(7.2)

35(5.1)

29(10.8)

 

Other

302(50.8)

146(45.6)

312(45.3)

126(47.0)

 

Longest place of residence in the last year

   

<.001

 

Home or with family

516(87.2)

300(90.6)

799(96.5)

258(95.2)

 

Care home

65(11.0)

30(9.1)

21(2.5)

10(3.7)

 

Other

11(1.9)

1(0.3)

8(1.0)

3(1.1)

 

Place of death

    

<.001

Home

196(33.2)

194(57.9)

377(45.5)

139(51.1)

 

Nursinghome/Residential home for older people

71(12.0)

28(8.4)

41(5.0)

11(4.0)

 

Hospital

198(33.5)

58(17.3)

312(37.7)

95(34.9)

 

Palliative Care Unit/Hospice

122(20.6)

54(16.1)

94(11.4)

26(9.6)

 

Elsewhere

4(0.7)

1(0.3)

4(0.5)

1(0.4)

 
  1. aMissing for age group: n = 5, gender: n = 4, Type of malignancy: n = 166, Longest place of residence last year: n = 15, Place of death: n = 11.
  2. bχ2test on cross-country differences.